Creative human-AI partnerships and AI-generated music: WaveAI CEO and co-founder Maya Ackerman speaks with Jon Krohn about learning to see – and accept – AI’s…
Thought Leader: Jon Krohn
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.
Creative human-AI partnerships and AI-generated music: WaveAI CEO and co-founder Maya Ackerman speaks with Jon Krohn about learning to see – and accept – AI’s…
Thought Leader: Jon Krohn
Dr. Sanjay Gupta: How to Safely Store Your Leftovers
We all have our cooking rituals, but are some of them unsafe? Dr. Sanjay Gupta gets to the bottom of handwashing hygiene, especially when handling…
Thought Leader: Sanjay Gupta
Ian Bremmer: “We’re not much closer to a ceasefire”
The Trump administration is pushing to secure a peace deal to end the war in Ukraine. But what that looks like and whether Russia is…
Thought Leader: Ian Bremmer